CA
NZ
UK
AU
IND
US
Elite Pharmaceuticals, Inc. filed a Form 8-K on November 12, 2026, announcing a conference call scheduled for November 13, 2026, to discuss financial results for its second quarter of fiscal year 2027, ended September 30, 2026.
Lisata Therapeutics, Inc. filed a Form 8-K/A (Amendment No. 1) on November 12, 2026, amending its September 17, 2026 Current Report to add audited and unaudited financial statements of acquired company Marea Therapeutics, Inc. and related pro forma financial information.
WEX Inc. filed a Form 8-K on November 12, 2026, disclosing that on November 10, 2026, the company and certain subsidiaries entered into the Eighth Amendment to its Amended and Restated Credit Agreement, extending the maturity of its revolving credit facility and tranche A …
International Money Express, Inc. filed a Form 8-K on November 12, 2026, disclosing that Western Union delivered a termination notice for their previously announced merger agreement on the evening of November 10, 2026, the same night the California Department of Financial Protection and Innovation …
MarineMax, Inc. filed an 8-K on November 12, 2026, reporting the results of a special shareholder meeting held November 11, 2026, at which shareholders voted to approve the company's proposed merger with an affiliate of Safe Harbor Marinas, LLC.
Edgewell Personal Care Company filed a Form 8-K on November 12, 2026, announcing the release of financial and operating results for its fourth quarter and fiscal year ended September 30, 2026.
Tetra Tech, Inc. filed a Form 8-K on November 12, 2026, reporting its fourth fiscal quarter financial results for the period ended September 27, 2026, and announcing a quarterly cash dividend declaration by its Board of Directors.
Murphy Oil Corporation filed a Form 8-K with the SEC on November 12, 2026, disclosing two separate exploration and production agreements: six exploration licenses awarded in Israel's Zone G and four production sharing contracts covering offshore Cameroon blocks.
Vylor Inc. filed a Form 8-K on November 12, 2026, attaching unaudited pro forma consolidated financial statements reflecting its separation from Corteva, Inc., which was completed on October 1, 2026.
CXJ Group Co., Limited filed a Form 8-K on November 12, 2026, disclosing the resignation of its independent registered public accounting firm, J & S Associate PLT., and the appointment of WSJ and Partners as its replacement.
Please wait processing your request...